{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T05:11:17Z","timestamp":1788844277900,"version":"build-2803163510"},"reference-count":162,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T00:00:00Z","timestamp":1678924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Behav. Neurosci."],"abstract":"<jats:p>Endocannabinoids (eCBs) and the expanded endocannabinoid system (ECS)-\u201cendocannabinoidome\u201d, consists of the endogenous ligands, eCBs, their canonical and non-canonical receptor subtypes, and their synthesizing and metabolizing enzymes. This system modulates a wide range of body functions and acts as a retrograde signaling system within the central nervous system (CNS) by inhibition of classical transmitters, and plays a vital modulatory function on dopamine, a major neurotransmitter in the CNS. Dopamine is involved in different behavioral processes and contributes to different brain disorders\u2014including Parkinson\u2019s disease, schizophrenia, and drug addiction. After synthesis in the neuronal cytosol, dopamine is packaged into synaptic vesicles until released by extracellular signals. Calcium dependent neuronal activation results in the vesicular release of dopamine and interacts with different neurotransmitter systems. The ECS, among others, is involved in the regulation of dopamine release and the interaction occurs either through direct or indirect mechanisms. The cross-talk between the ECS and the dopaminergic system has important influence in various dopamine-related neurobiological and pathologic conditions and investigating this interaction might help identify therapeutic targets and options in disorders of the CNS associated with dopamine dysregulation.<\/jats:p>","DOI":"10.3389\/fnbeh.2023.1137957","type":"journal-article","created":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T06:39:01Z","timestamp":1678948741000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":30,"title":["Crosstalk between the endocannabinoid and mid-brain dopaminergic systems: Implication in dopamine dysregulation"],"prefix":"10.3389","volume":"17","author":[{"given":"Berhanu Geresu","family":"Kibret","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Canseco-Alba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel S.","family":"Onaivi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ephrem","family":"Engidawork","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,3,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1177\/1073858403252674","article-title":"Prefrontal DA transmission at D1 receptors and the pathology of schizophrenia","volume":"9","author":"Abi-dargham","year":"2003","journal-title":"Neuroscientist"},{"key":"B2","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.pbb.2004.04.013","article-title":"Preclinical models of sexual desire: conceptual and behavioral analyses","volume":"78","author":"\u00c5gmo","year":"2004","journal-title":"Pharmacol. Biochem. Behav."},{"key":"B3","doi-asserted-by":"publisher","first-page":"pyu035","DOI":"10.1093\/ijnp\/pyu035","article-title":"Increasing endocannabinoid levels in the ventral pallidum restore aberrant dopamine neuron activity in the subchronic PCP rodent model of schizophrenia","volume":"18","author":"Aguilar","year":"2015","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.molmed.2012.07.009","article-title":"The endocannabinoid system in inflammatory bowel diseases: from pathophysiology to therapeutic opportunity","volume":"18","author":"Alhouayek","year":"2012","journal-title":"Trends Mol. Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0014-2999(67)90057-x","article-title":"Effects of reserpine and a tyrosine hydroxylase inhibitor on the monoamine levels in different regions of the rat central nervous system","volume":"1","author":"And\u00e9n","year":"1967","journal-title":"Eur. J. Pharmacol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"146","DOI":"10.4103\/0973-1229.58825","article-title":"Stahl\u2019s essential psychopharmacology: neuroscientific basis and practical applications","volume":"8","author":"Andrade","year":"2010","journal-title":"Mens Sana Monogr."},{"key":"B7","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1038\/sj.npp.1300350","article-title":"Sexual behavior and sex-associated environmental cues activate the mesolimbic system in male rats","volume":"29","author":"Balfour","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"B8","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1080\/09540260902782786","article-title":"Cannabinoid CB1 receptor antagonists as potential pharmacotherapies for drug abuse disorders","volume":"21","author":"Beardsley","year":"2009","journal-title":"Int. Rev. Psychiatry"},{"key":"B9","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1073\/pnas.62.3.741","article-title":"Release of newly synthesized dopamine from dopamine-containing terminals in the striatum of the rat","volume":"62","author":"Besson","year":"1969","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"B10","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3389\/fnbeh.2019.00257","article-title":"The sexual motivation of male rats as a tool in animal models of human health disorders","volume":"13","author":"Bialy","year":"2019","journal-title":"Front. Behav. Neurosci."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1007\/s00213-018-4885-9","article-title":"The effects of cannabidiol (CBD) on cognition and symptoms in outpatients with chronic schizophrenia a randomized placebo controlled trial","volume":"235","author":"Boggs","year":"2018","journal-title":"Psychopharmacology (Berl)."},{"key":"B12","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/npp.2008.138","article-title":"\u03949-Tetrahydrocannabinol induces dopamine release in the human striatum","volume":"34","author":"Bossong","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/C2009-0-00066-X","author":"Brady","year":"2012","journal-title":"Basic Neurochemistry. Elsevier"},{"key":"B14","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/s0306-4522(01)00210-x","article-title":"Conditioned place preference induced by the cannabinoid agonist CP 55,940: interaction with the opioid system","volume":"923","author":"Braida","year":"2001","journal-title":"Neuroscience"},{"key":"B15","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/s0167-4781(02)00341-x","article-title":"Cloning and molecular characterization of the rat CB2 cannabinoid receptor","volume":"1576","author":"Brown","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"key":"B16","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1002\/syn.20569","article-title":"Postsynaptic localization of CB2 cannabinoid receptors in the rat hippocampus","volume":"62","author":"Brusco","year":"2008","journal-title":"Synapse"},{"key":"B17","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/0166-4328(90)90091-r","article-title":"6-Hydroxydopamine lesion of the rat prefrontal cortex increases locomotor activity, impairs acquisition of delayed alternation tasks, but does not affect uninterrupted tasks in the radial maze","volume":"37","author":"Bubser","year":"1990","journal-title":"Behav. Brain Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"4071","DOI":"10.1007\/s00213-014-3547-9","article-title":"Low anandamide doses facilitate male rat sexual behaviour through the activation of CB1 receptors","volume":"231","author":"Canseco-Alba","year":"2014","journal-title":"Psychopharmacology (Berl)."},{"key":"B19","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.pbb.2016.11.004","article-title":"Intra-VTA anandamide infusion produces dose-based biphasic effects on male rat sexual behavior expression","author":"Canseco-Alba","year":"2016","journal-title":"Pharmacol. Biochem. Behav."},{"key":"B20","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3389\/fnbeh.2019.00184","article-title":"Endocannabinoids interact with the dopaminergic system to increase sexual motivation: lessons from the sexual satiety phenomenon","volume":"13","author":"Canseco-Alba","year":"2019","journal-title":"Front. Behav. Neurosci."},{"key":"B210","doi-asserted-by":"publisher","first-page":"803394","DOI":"10.3389\/fpsyt.2021.803394","article-title":"Cell-type specific deletion of CB2 cannabinoid receptors in dopamine neurons induced hyperactivity phenotype: possible relevance to attention-deficit hyperactivity disorder","volume":"12","author":"Canseco-Alba","year":"2022","journal-title":"Front. Psychiatry"},{"key":"B21","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.bbr.2018.11.043","article-title":"Behavioral effects of psychostimulants in mutant mice with cell-type specific deletion of CB2 cannabinoid receptors in dopamine neurons","volume":"360","author":"Canseco-Alba","year":"2019","journal-title":"Behav. Brain Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1126\/science.127.3296.471","article-title":"On the presence of 3-hydroxytyramine in brain","volume":"127","author":"Carlsson","year":"1958","journal-title":"Science"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1212\/01.wnl.0000140288.48796.8e","article-title":"Cannabis for dyskinesia in Parkinson disease: a randomized double-blind crossover study","volume":"63","author":"Carroll","year":"2004","journal-title":"Neurology"},{"key":"B24","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.bbrc.2009.08.037","article-title":"Anandamide increases swelling and reduces calcium sensitivity of mitochondria","volume":"388","author":"Catanzaro","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1177\/0269881114550355","article-title":"Effects of cannabidiol in the treatment of patients with Parkinson\u2019s disease: an exploratory double-blind trial","volume":"28","author":"Chagas","year":"2014","journal-title":"J. Psychopharmacol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1615\/critrevneurobiol.v13.i3.20","article-title":"Behavioral effects of cannabinoid agents in animals","volume":"13","author":"Chaperon","year":"1999","journal-title":"Crit. Rev. Neurobiol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/s0028-3908(03)00029-7","article-title":"Differential cannabinoid-induced electrophysiological effects in rat ventral tegmentum","volume":"44","author":"Cheer","year":"2003","journal-title":"Neuropharmacology"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1210\/en.2007-0966","article-title":"A role for intestinal endocrine cell-expressed G protein-coupled receptor 119 in glycemic control by enhancing glucagon-like peptide-1 and glucose-dependent insulinotropic peptide release","volume":"149","author":"Chu","year":"2008","journal-title":"Endocrinology"},{"key":"B29","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1097\/00008877-200209000-00018","article-title":"SR141716, a central cannabinoid (CB1) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats","volume":"13","author":"Cohen","year":"2002","journal-title":"Behav. Pharmacol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s002130100887","article-title":"Stimulation of voluntary ethanol intake by cannabinoid receptor agonists in ethanol-preferring sP rats","volume":"159","author":"Colombo","year":"2002","journal-title":"Psychopharmacology (Berl)."},{"key":"B31","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.neuropharm.2017.04.033","article-title":"Endocannabinoid modulation of dopamine neurotransmission","volume":"124","author":"Covey","year":"2017","journal-title":"Neuropharmacology"},{"key":"B32","doi-asserted-by":"publisher","first-page":"734975","DOI":"10.3389\/fnsyn.2021.734975","article-title":"Endocannabinoid modulation of nucleus accumbens microcircuitry and terminal dopamine release","volume":"13","author":"Covey","year":"2021","journal-title":"Front. Synaptic Neurosci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1111\/jcpt.12018","article-title":"Cannabidiol for the treatment of cannabis withdrawal syndrome: a case report","volume":"38","author":"Crippa","year":"2013","journal-title":"J. Clin. Pharm. Ther."},{"key":"B34","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41582-019-0284-z","article-title":"Cannabinoids and the expanded endocannabinoid system in neurological disorders","volume":"16","author":"Cristino","year":"2020","journal-title":"Nat. Rev. Neurol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1088\/1748-605X\/acbf15","article-title":"Cannabinoids and Psychosis","volume":"78","author":"D\u2019Souza","year":"2007","journal-title":"Int. Rev. Neurobiol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1093\/alcalc\/agh110","article-title":"The endocannabinoid system: physiology and pharmacology","volume":"40","author":"de Fonseca","year":"2005","journal-title":"Alcohol Alcohol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"105357","DOI":"10.1016\/j.phrs.2020.105357","article-title":"Crosstalk between the transcriptional regulation of dopamine D2 and cannabinoid CB1 receptors in schizophrenia: analyses in patients and in perinatal \u03949-tetrahydrocannabinol-exposed rats","volume":"164","author":"Di Bartolomeo","year":"2021","journal-title":"Pharmacol. Res."},{"key":"B38","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.neuropharm.2004.06.032","article-title":"Dopamine and drug addiction: The nucleus accumbens shell connection","volume":"47","author":"Di Chiara","year":"2004","journal-title":"Neuropharmacology"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.phrs.2020.105357","article-title":"Endocannabinoids: synthesis and degradation","volume":"47","author":"Di Marzo","year":"2006","journal-title":"Rev. Physiol. Biochem. Pharmacol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"259","DOI":"10.31887\/DCNS.2020.22.3\/vdimarzo","article-title":"The endocannabinoidome as a substrate for noneuphoric phytocannabinoid action and gut microbiome dysfunction in neuropsychiatric disorders","volume":"22","author":"Di Marzo","year":"2020","journal-title":"Dialogues Clin. Neurosci."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.3390\/nu11081956","article-title":"Lifestyle and metabolic syndrome: contribution of the endocannabinoidome","volume":"11","author":"Di Marzo","year":"2019","journal-title":"Nutrients"},{"key":"B42","doi-asserted-by":"publisher","first-page":"110031","DOI":"10.1016\/j.pnpbp.2020.110031","article-title":"Endocannabinoid modulation of dopamine release during reward seeking, interval timing and avoidance","volume":"104","author":"Everett","year":"2021","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"B43","doi-asserted-by":"publisher","first-page":"S97","DOI":"10.1016\/j.mce.2008.02.006","article-title":"Neurobiological mechanisms of cannabinoid addiction","volume":"286","author":"Fattore","year":"2008","journal-title":"Mol. Cell. Endocrinol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1186\/s12937-023-00841-0","article-title":"The endocannabinoid system as a target for the treatment of motor dysfunction","volume":"156","author":"Fern\u00e1ndez-Ruiz","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1186\/s12937-023-00841-0","article-title":"Cannabinoid control of motor function at the basal ganglia","volume":"168","author":"Fern\u00e1ndez-Ruiz","year":"2005","journal-title":"Handb. Exp. Pharmacol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"e72","DOI":"10.1111\/j.1755-5949.2010.00144.x","article-title":"Cannabinoid-dopamine interaction in the pathophysiology and treatment of CNS disorders","volume":"16","author":"Fern\u00e1ndez-Ruiz","year":"2010","journal-title":"CNS Neurosci. Ther."},{"key":"B47","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1054\/plef.2001.0350","article-title":"Endocannabinoids and basal ganglia functionality","volume":"66","author":"Fern\u00e1ndez-Ruiz","year":"2002","journal-title":"Prostaglandins Leukot. Essent. Fatry Acids"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1046\/j.1460-9568.2003.02896.x","article-title":"Effects of levodopa on endocannabinoid levels in rat basal ganglia: implications for the treatment of levodopa-induced dyskinesias","volume":"18","author":"Ferrer","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"B49","doi-asserted-by":"publisher","first-page":"4849","DOI":"10.1523\/JNEUROSCI.17-12-04849.1997","article-title":"Dynamic changes in nucleus accumbens dopamine efflux during the Coolidge effect in male rats","volume":"17","author":"Fiorino","year":"1997","journal-title":"J. Neurosci."},{"key":"B50","doi-asserted-by":"publisher","first-page":"4013","DOI":"10.1002\/cne.23141","article-title":"Altered dendritic distribution of dopamine D2 receptors and reduction in mitochondrial number in parvalbumin-containing interneurons in the medial prefrontal cortex of cannabinoid-1 (CB1) receptor knockout mice","volume":"520","author":"Fitzgerald","year":"2012","journal-title":"J. Comp. Neurol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s00213-006-0404-5","article-title":"Mesocortical dopamine modulation of executive functions: Beyond working memory","volume":"188","author":"Floresco","year":"2006","journal-title":"Psychopharmacology (Berl)."},{"key":"B52","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.ejphar.2005.09.025","article-title":"The role of dopamine in human addiction: from reward to motivated attention","volume":"526","author":"Franken","year":"2005","journal-title":"Europ. J. Pharmacol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/s0014-5793(03)01196-7","article-title":"Seven evolutionarily conserved human rhodopsin G protein-coupled receptors lacking close relatives","volume":"554","author":"Fredriksson","year":"2003","journal-title":"FEBS Lett."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1176\/appi.ajp.2010.09060784","article-title":"Expression of interneuron markers in the dorsolateral prefrontal cortex of the developing human and in schizophrenia","volume":"167","author":"Fung","year":"2010","journal-title":"Am. J. Psychiatry"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms22010134","article-title":"Possible receptor mechanisms underlying cannabidiol effects on addictive-like behaviors in experimental animals","volume":"22","author":"Galaj","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B56","doi-asserted-by":"publisher","first-page":"54","DOI":"10.18240\/ijo.2023.02.02","article-title":"Expression of Central and Peripheral Cannabinoid Receptors in Human Immune Tissues and Leukocyte Subpopulations","volume":"232","author":"Gali\u00e8gue","year":"1995","journal-title":"Eur. J. Biochem."},{"key":"B57","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1021\/ja01062a046","article-title":"Isolation, structure and partial synthesis of an active constituent of Hashish","volume":"86","author":"Gaoni","year":"1964","journal-title":"J. Am. Chem. Soc."},{"key":"B58","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s12934-022-01952-9","article-title":"Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson\u2019s disease: importance of antioxidant and cannabinoid receptor-independent properties","volume":"1134","author":"Garc\u00eda-Arencibia","year":"2007","journal-title":"Brain Res."},{"key":"B59","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1111\/bph.13215","article-title":"Cannabinoid-dopamine interactions in the physiology and physiopathology of the basal ganglia","volume":"21","author":"Garc\u00eda","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.pbb.2005.01.032","article-title":"Endocannabinoid signaling system and brain reward: emphasis on dopamine","volume":"81","author":"Gardner","year":"2005","journal-title":"Pharmacol. Biochem. Behav."},{"key":"B61","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/978-0-387-74349-3_21","article-title":"The endocannabinoid system in the physiology and pathology of the basal ganglia","volume-title":"Cannabinoids and the Brain","author":"Gerdeman","year":"2008"},{"key":"B62","doi-asserted-by":"publisher","first-page":"3164","DOI":"10.3390\/molecules24173164","article-title":"Involvement of CB2 receptors in the neurobehavioral effects of Catha edulis (Vahl) Endl. (khat) in mice","volume":"24","author":"Geresu","year":"2019","journal-title":"Molecules"},{"key":"B63","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.brainres.2016.08.006","article-title":"Behavioral evidence for the interaction between cannabinoids and Catha edulis F. (Khat) in mice","volume":"1648","author":"Geresu","year":"2016","journal-title":"Brain Res."},{"key":"B64","doi-asserted-by":"publisher","first-page":"5327","DOI":"10.1523\/JNEUROSCI.17-14-05327.1997","article-title":"Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a G(s) linkage to the CB1 receptor","volume":"17","author":"Glass","year":"1997","journal-title":"J. Neurosci."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1124\/mol.56.6.1362","article-title":"Agonist selective regulation of G proteins by cannabinoid CB1 and CB2 receptors","volume":"56","author":"Glass","year":"1999","journal-title":"Mol. Pharmacol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.pbb.2005.01.028","article-title":"Cannabinoid tolerance and dependence: a review of studies in laboratory animals","volume":"56","author":"Gonz\u00e1lez","year":"2005","journal-title":"Pharmacol. Biochem. Behav."},{"key":"B67","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1021\/cn500235m","article-title":"Loss of dopamine D2 receptors increases parvalbumin-positive interneurons in the anterior cingulate cortex","volume":"6","author":"Graham","year":"2015","journal-title":"ACS Chem. Neurosci."},{"key":"B68","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/s0014-2999(99)00402-1","article-title":"Evaluation of the cannabinoid CB2 receptor-selective antagonist, SR144528: Further evidence for cannabinoid CB2 receptor absence in the rat central nervous system","volume":"377","author":"Griffin","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0074-7742(06)78001-1","article-title":"Neurobiology of dopamine in schizophrenia","volume":"377","author":"Guillin","year":"2007","journal-title":"Int. Rev. Neurobiol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1756-6606-4-26","article-title":"Dopamine D1\u2013D2 receptor heteromer signaling pathway in the brain: emerging physiological relevance","volume":"4","author":"Hasbi","year":"2011","journal-title":"Mol. Brain"},{"key":"B71","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.neuron.2005.01.004","article-title":"Phospholipase C\u03b2 serves as a coincidence detector through its Ca2+ dependency for triggering retrograde endocannabinoid signal","volume":"45","author":"Hashimotodani","year":"2005","journal-title":"Neuron"},{"key":"B72","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.molmet.2014.03.007","article-title":"Cannabinoid control of brain bioenergetics: exploring the subcellular localization of the CB1 receptor","volume":"3","author":"Hebert-Chatelain","year":"2014","journal-title":"Mol. Metab."},{"key":"B73","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1523\/JNEUROSCI.11-02-00563.1991","article-title":"Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study","volume":"11","author":"Herkenham","year":"1991","journal-title":"J. Neurosci."},{"key":"B74","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/s0031-9384(96)00367-8","article-title":"Subcortical multiple unit activity changes during rat male sexual behavior","volume":"61","author":"Hernandez-Gonzalez","year":"1997","journal-title":"Physiol. Behav."},{"key":"B75","first-page":"727","article-title":"Demonstration and mapping of central neurons containing dopamine, noradrenaline and 5-hydroxytryptamine and their reactions to psychopharmaca","volume":"18","author":"Hillarp","year":"1966","journal-title":"Pharmacol. Rev."},{"key":"B76","first-page":"53","article-title":"\u201cCannabinoid receptor signaling","volume-title":"Handbook of Experimental Pharmacology","author":"Howlett","year":"2005"},{"key":"B77","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1046\/j.1471-4159.2003.01576.x","article-title":"Cannabinoid CB1 receptor knockout mice exhibit markedly reduced voluntary alcohol consumption and lack alcohol-induced dopamine release in the nucleus accumbens","volume":"84","author":"Hungud","year":"2003","journal-title":"J. Neurochem."},{"key":"B78","doi-asserted-by":"publisher","first-page":"586","DOI":"10.3390\/cells10030586","article-title":"The endocannabinoid system and ppars: focus on their signalling crosstalk, action and transcriptional regulation","volume":"10","author":"Iannotti","year":"2021","journal-title":"Cells"},{"key":"B79","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.nbd.2016.04.004","article-title":"Energy deficit in parvalbumin neurons leads to circuit dysfunction, impaired sensory gating and social disability","volume":"93","author":"Inan","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"B80","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/sj.tpj.6500431","article-title":"Involvement of cannabinoid CB2 receptor in alcohol preference in mice and alcoholism in humans","volume":"7","author":"Ishiguro","year":"2007","journal-title":"Pharmacogenomics J."},{"key":"B81","volume-title":"Dopamine Handbook","author":"Iversen","year":"2010"},{"key":"B82","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1111\/j.1742-7843.2006.pto_376.x","article-title":"The endocannabinoid system: current pharmacological research and therapeutic possibilities","volume":"98","author":"Jonsson","year":"2006","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-030-21737-2_1","article-title":"Endocannabinoid system components: overview and tissue distribution","volume":"1162","author":"Joshi","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/s0306-4522(03)00070-8","article-title":"Neuroanatomical relationship between type 1 cannabinoid receptors and dopaminergic systems in the rat basal ganglia","volume":"119","author":"Julian","year":"2003","journal-title":"Neuroscience"},{"key":"B85","doi-asserted-by":"publisher","first-page":"3306","DOI":"10.1523\/JNEUROSCI.22-09-03306.2002","article-title":"The neuroscience of natural rewards: relevance to addictive drugs","volume":"22","author":"Kelley","year":"2002","journal-title":"J. Neurosci."},{"key":"B86","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1038\/s41380-021-01313-9","article-title":"Mitochondrial, exosomal miR137-COX6A2 and gamma synchrony as biomarkers of parvalbumin interneurons, psychopathology and neurocognition in schizophrenia","volume":"27","author":"Khadimallah","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"B87","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/sj.bjp.0704767","article-title":"Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol","volume":"136","author":"Kirkham","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/j.1600-0773.1997.tb00039.x","article-title":"Molecular characteristics of mammalian dopamine receptors","volume":"81","author":"Lachowicz","year":"1997","journal-title":"Pharmacol. Toxicol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.3390\/ijms22031001","article-title":"Relevance of peroxisome proliferator activated receptors in multitarget paradigm associated with the endocannabinoid system","volume":"22","author":"Lago-Fernandez","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B90","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s00702-021-02326-y","article-title":"Endocannabinoid and dopaminergic system: the pas de deux underlying human motivation and behaviors","volume":"128","author":"Laksmidewi","year":"2021","journal-title":"J. Neural Transm."},{"key":"B91","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.cca.2021.08.009","article-title":"Dopamine in Parkinson\u2019s disease","volume":"522","author":"Latif","year":"2021","journal-title":"Clin. Chim. Acta"},{"key":"B92","doi-asserted-by":"publisher","first-page":"19144","DOI":"10.1073\/pnas.0509588102","article-title":"The cannabinoid agonist WIN55,212\u20132 increases intracellular calcium via CB1 receptor coupling to Gq\/11 G proteins","volume":"102","author":"Lauckner","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"B93","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1124\/jpet.104.077974","article-title":"Cannabinoid CB1 receptor antagonists as promising new medications for drug dependence","volume":"312","author":"Le Foll","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B94","doi-asserted-by":"publisher","first-page":"e94","DOI":"10.1038\/tp.2012.15","article-title":"Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia","volume":"2","author":"Leweke","year":"2012","journal-title":"Transl. Psychiatry"},{"key":"B96","doi-asserted-by":"publisher","first-page":"17410","DOI":"10.1038\/s41598-017-17796-y","article-title":"Cannabinoid type 2 receptors in dopamine neurons inhibits psychomotor behaviors, alters anxiety, depression and alcohol preference","volume":"7","author":"Liu","year":"2017","journal-title":"Sci. Rep."},{"key":"B95","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuropharm.2007.05.020","article-title":"Multiple pathways involved in the biosynthesis of anandamide","volume":"54","author":"Liu","year":"2008","journal-title":"Neuropharmacology"},{"key":"B97","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1097\/WNF.0000000000000016","article-title":"Cannabis (Medical Marijuana) treatment for motor and non-motor symptoms of parkinson disease: an open-label observational study","volume":"37","author":"Lotan","year":"2014","journal-title":"Clin. Neuropharmacol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/sj.bjp.0705931","article-title":"Marijuana and cannabinoid regulation of brain reward circuits","volume":"143","author":"Lupica","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.tins.2006.01.008","article-title":"Involvement of the endocannabinoid system in drug addiction","volume":"29","author":"Maldonado","year":"2006","journal-title":"Trends Neurosci."},{"key":"B100","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.bcp.2018.09.013","article-title":"Role of the endocannabinoid system in drug addiction","volume":"157","author":"Manzanares","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.3389\/fphar.2020.01003","article-title":"Dopamine receptor subtypes, physiology and pharmacology: new ligands and concepts in schizophrenia","volume":"11","author":"Martel","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B102","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-319-56015-1_461-1","article-title":"The endocannabinoid system in the central nervous system: emphasis on the role of the mitochondrial cannabinoid receptor 1 (mtCB1R)","volume-title":"Neuropsychopharmacotherapy","author":"Maya-L\u00f3pez","year":"2021"},{"key":"B103","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1176\/appi.ajp.2017.17030325","article-title":"Cannabidiol (CBD) as an adjunctive therapy in schizophrenia: a multicenter randomized controlled trial","volume":"175","author":"McGuire","year":"2018","journal-title":"Am. J. Psychiatry"},{"key":"B105","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/0149-7634(94)00020-2","article-title":"Dopamine and sexual behavior","volume":"19","author":"Melis","year":"1995","journal-title":"Neurosci. Biobehav. Rev."},{"key":"B104","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/s0278-5846(00)00119-6","article-title":"Different mechanisms for dopaminergic excitation induced by opiates and cannabinoids in the rat midbrain","volume":"24","author":"Melis","year":"2000","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"B106","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1176\/appi.ajp.161.6.975","article-title":"Placebo-controlled evaluation of four novel compounds for the treatment of schizophrenia and schizoaffective disorder","volume":"161","author":"Meltzer","year":"2004","journal-title":"Am. J. Psychiatry"},{"key":"B107","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1176\/appi.ajp.161.6.975","article-title":"Neurokinin B, neurotensin and cannabinoid receptor antagonists and Parkinson disease","volume":"27","author":"Mesnage","year":"2004","journal-title":"Clin. Neuropharmacol."},{"key":"B108","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1192\/bjp.bp.110.077503","article-title":"Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study","volume":"197","author":"Morgan","year":"2010","journal-title":"Br. J. Psychiatry"},{"key":"B109","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1586\/14737175.8.7.1037","article-title":"Cannabis and schizophrenia: towards a cannabinoid hypothesis of schizophrenia","volume":"8","author":"M\u00fciller-Vahl","year":"2008","journal-title":"Expert Rev. Neurother."},{"key":"B110","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/365061a0","article-title":"Molecular characterization of a peripheral receptor for cannabinoids","volume":"365","author":"Munro","year":"1993","journal-title":"Nature"},{"key":"B111","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/j.bbrc.2007.08.078","article-title":"Identification of GPR55 as a lysophosphatidylinositol receptor","volume":"365","author":"Oka","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B112","doi-asserted-by":"publisher","first-page":"a012229","DOI":"10.1101\/cshperspect.a012229","article-title":"A brain on cannabinoids: the role of dopamine release in reward seeking","volume":"2","author":"Oleson","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"B113","doi-asserted-by":"publisher","first-page":"660218","DOI":"10.3389\/fnsyn.2021.660218","article-title":"Cannabinoid modulation of dopamine release during motivation, periodic reinforcement, exploratory behavior, habit formation and attention","volume":"13","author":"Oleson","year":"2021","journal-title":"Front. Synaptic Neurosci."},{"key":"B114","first-page":"1002","article-title":"Pharmacological characterization of cannabinoids in the elevated plus maze","volume":"253","author":"Onaivi","year":"1990","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B115","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1196\/annals.1369.052","article-title":"Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain","volume":"1074","author":"Onaivi","year":"2006","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"B116","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/s0301-0082(02)00007-2","article-title":"Endocannabinoids and cannabinoid receptor genetics","volume":"66","author":"Onaivi","year":"2002","journal-title":"Prog. Neurobiol."},{"key":"B117","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.cmet.2006.02.004","article-title":"Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents","volume":"3","author":"Overton","year":"2006","journal-title":"Cell Metab."},{"key":"B118","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/nrn4004","article-title":"Endocannabinoid signalling in reward and addiction","volume":"16","author":"Parsons","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"key":"B119","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1054\/plef.2001.0341","article-title":"Cannabinoid receptors and their ligands","volume":"66","author":"Pertwee","year":"2002","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"B120","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.tins.2021.02.001","article-title":"Modulating the neuromodulators: dopamine, serotonin and the endocannabinoid system","volume":"44","author":"Peters","year":"2021","journal-title":"Trends Neurosci."},{"key":"B121","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/0006-8993(90)91309-5","article-title":"Sexual behavior enhances central dopamine transmission in the male rat","volume":"530","author":"Pfaus","year":"1990","journal-title":"Brain Res."},{"key":"B122","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1046\/j.0953-816x.2001.01612.x","article-title":"Effects of cannabinoids on prefrontal neuronal responses to ventral tegmental area stimulation","volume":"14","author":"Pistis","year":"2001","journal-title":"Eur. J. Neurosci."},{"key":"B123","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/sj.bjp.0707567","article-title":"Targeting the cannabinoid CB2 receptor: modelling and structural determinants of CB2 selective ligands","volume":"153","author":"Poso","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"B124","first-page":"1000","article-title":"Activation of cannabinoid receptors in rat brain by WIN 55212-2 produces coupling to multiple G protein \u03b1-subunits with different potencies","volume":"57","author":"Prather","year":"2000","journal-title":"Mol. Pharmacol."},{"key":"B125","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1111\/j.1460-9568.2009.06764.x","article-title":"WIN55,212-2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson\u2019s disease","volume":"29","author":"Price","year":"2009","journal-title":"Eur. J. Neurosci."},{"key":"B126","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1046\/j.1471-4159.1998.71041525.x","article-title":"Cannabinoid receptor activation differentially regulates the various adenylyl cyclase isozymes","volume":"71","author":"Rhee","year":"1998","journal-title":"J. Neurochem."},{"key":"B127","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1097\/00001756-200108080-00051","article-title":"Sub-second changes in accumbal dopamine during sexual behavior in male rats","volume":"12","author":"Robinson","year":"2001","journal-title":"Neuroreport"},{"key":"B128","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/0166-4328(94)90019-1","article-title":"Reversal of sexual exhaustion by serotonergic and noradrenergic agents","volume":"62","author":"Rodr\u00edguez-Manzo","year":"1994","journal-title":"Behav. Brain Res."},{"key":"B129","doi-asserted-by":"publisher","first-page":"112510","DOI":"10.1016\/j.bbr.2020.112510","article-title":"Endocannabinoids mediate long-lasting behavioural and physiological changes in male rats induced by the repeated activation of the mesolimbic system by copulation to satiety","volume":"383","author":"Rodr\u00edguez-Manzo","year":"2020","journal-title":"Behav. Brain Res."},{"key":"B130","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/bs.irn.2015.10.004","article-title":"Endocannabinoid signaling in motivation, reward and addiction: influences on mesocorticolimbic dopamine function","volume":"125","author":"Sagheddu","year":"2015","journal-title":"Int. Rev. Neurobiol."},{"key":"B131","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/s0024-3205(99)00293-3","article-title":"Motor actions of cannabinoids in the basal ganglia output nuclei","volume":"65","author":"Sa\u00f1udo-Pe\u00f1a","year":"1999","journal-title":"Life Sci."},{"key":"B132","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1152\/jn.1994.71.2.515","article-title":"The role of D1-dopamine receptor in working memory: Local injections of dopamine antagonists into the prefrontal cortex of rhesus monkeys performing an oculomotor delayed-response task","volume":"71","author":"Sawaguchi","year":"1994","journal-title":"J. Neurophysiol."},{"key":"B133","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1111\/j.1471-4159.1988.tb10583.x","article-title":"[3H]Dihydrotetrabenazine, a new in vitro monoaminergic probe for human brain","volume":"50","author":"Scherman","year":"1988","journal-title":"J. Neurochem."},{"key":"B134","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1111\/j.1476-5381.2010.00735.x","article-title":"The endocannabinoid system as a target for the treatment of neurodegenerative disease","volume":"160","author":"Scotter","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"B135","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.neuropharm.2011.05.034","article-title":"Endocannabinoid-mediated synaptic plasticity and addiction-related behavior","volume":"61","author":"Sidhpura","year":"2011","journal-title":"Neuropharmacology"},{"key":"B136","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.neubiorev.2016.09.007","article-title":"Seeing through the smoke: Human and animal studies of cannabis use and endocannabinoid signalling in corticolimbic networks","volume":"76","author":"Silveira","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"key":"B137","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1038\/sj.npp.1300707","article-title":"Lack of CBI cannabinoid receptor impairs cocaine self-administration","volume":"30","author":"Soria","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"B138","doi-asserted-by":"publisher","first-page":"e271","DOI":"10.1371\/journal.pbio.0030271","article-title":"Dopamine-independent locomotor actions of amphetamines in a novel acute mouse model of parkinson disease","volume":"3","author":"Sotnikova","year":"2005","journal-title":"PLoS Biol."},{"key":"B139","doi-asserted-by":"publisher","first-page":"241","DOI":"10.31887\/DCNS.2020.22.3\/rspanagel","article-title":"Cannabinoids and the endocannabinoid system in reward processing and addiction: from mechanisms to interventions","volume":"22","author":"Spanagel","year":"2020","journal-title":"Dialogues Clin. Neurosci."},{"key":"B140","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.pharmthera.2007.01.005","article-title":"Biochemistry and pharmacology of endovanilloids","volume":"114","author":"Starowicz","year":"2007","journal-title":"Pharmacol. Ther."},{"key":"B141","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/s0091-3057(97)00422-x","article-title":"Biphasic effects of anandamide","volume":"59","author":"Sulcova","year":"1998","journal-title":"Pharmacol. Biochem. Behav."},{"key":"B142","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.yhbeh.2008.08.012","article-title":"Sexual reward in male rats: effects of sexual experience on conditioned place preferences associated with ejaculation and intromissions","volume":"55","author":"Tenk","year":"2009","journal-title":"Horm. Behav."},{"key":"B143","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1093\/cercor\/bhl034","article-title":"Dopamine modulation of prefrontal cortical interneurons changes during adolescence","volume":"17","author":"Tseng","year":"2007","journal-title":"Cereb. Cortex"},{"key":"B144","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/s0306-4522(97)00436-3","article-title":"Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system","volume":"83","author":"Tsou","year":"1998","journal-title":"Neuroscience"},{"key":"B145","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1677\/JME-08-0190","article-title":"Signal transduction of the CB1 cannabinoid receptor","volume":"44","author":"Turu","year":"2010","journal-title":"J. Mol. Endocrinol."},{"key":"B146","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/sj.bjp.0705100","article-title":"The CB1 receptor antagonist SR141716A selectively increases monoaminergic neurotransmission in the medial prefrontal cortex: Implications for therapeutic actions","volume":"138","author":"Tzavara","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"B147","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.euroneuro.2008.11.003","article-title":"CB1 receptor knockout mice are hyporesponsive to the behavior-stimulating actions of d-amphetamine: role of mGlu5 receptors","volume":"19","author":"Tzavara","year":"2009","journal-title":"Eur. Neuropsychopharmacol."},{"key":"B148","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.biopsych.2005.08.019","article-title":"Endocannabinoids activate transient receptor potential vanilloid 1 receptors to reduce hyperdopaminergia-related hyperactivity: therapeutic implications","volume":"59","author":"Tzavara","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"B149","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/sj.mp.4001029","article-title":"CNR1, central cannabinoid receptor gene, associated with susceptibility to hebephrenic schizophrenia","volume":"7","author":"Ujike","year":"2002","journal-title":"Mol. Psychiatry"},{"key":"B150","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0306-039x(76)90016-7","article-title":"6-hydroxydopamine-induced degeneration of the nigrostriatal dopamine pathway: The turning syndrome","volume":"2","author":"Ungerstedt","year":"1976","journal-title":"Pharmacol. Ther. B"},{"key":"B151","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/sj.bjp.0704479","article-title":"Behavioural and biochemical evidence for interactions between \u03949-tetrahydrocannabinol and nicotine","volume":"135","author":"Valjent","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"B152","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1126\/science.1115740","article-title":"Neuroscience: identification and functional characterization of brainstem cannabinoid CB2 receptors","volume":"310","author":"Van Sickle","year":"2005","journal-title":"Science"},{"key":"B153","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s11892-019-1248-9","article-title":"The expanded endocannabinoid system\/endocannabinoidome as a potential target for treating diabetes mellitus","volume":"19","author":"Veilleux","year":"2019","journal-title":"Curr. Diab. Rep."},{"key":"B154","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1002\/mds.20111","article-title":"Survey on cannabis use in Parkinson\u2019s disease: subjective improvement of motor symptoms","volume":"19","author":"Venderov\u00e1","year":"2004","journal-title":"Mov. Disord."},{"key":"B155","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/s0925-4927(01)00104-4","article-title":"Cannabis induced dopamine release: an in-vivo SPECT study","volume":"107","author":"Voruganti","year":"2001","journal-title":"Psychiatry Res."},{"key":"B156","doi-asserted-by":"publisher","first-page":"832854","DOI":"10.3389\/fncel.2022.832854","article-title":"Roles of the cannabinoid system in the basal ganglia in Parkinson\u2019s disease","volume":"16","author":"Wang","year":"2022","journal-title":"Front. Cell. Neurosci."},{"key":"B157","doi-asserted-by":"publisher","first-page":"108736","DOI":"10.1016\/j.neuropharm.2021.108736","article-title":"Mechanisms of endocannabinoid control of synaptic plasticity","volume":"197","author":"Winters","year":"2021","journal-title":"Neuropharmacology"},{"key":"B158","doi-asserted-by":"publisher","first-page":"E5007","DOI":"10.1073\/pnas.1413210111","article-title":"Cannabinoid CB2 receptors modulate midbrain dopamine neuronal activity and dopamine-related behavior in mice","volume":"111","author":"Zhang","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"B159","doi-asserted-by":"publisher","first-page":"10230","DOI":"10.1523\/JNEUROSCI.1712-16.2016","article-title":"Drug-induced alterations of endocannabinoid-mediated plasticity in brain reward regions","volume":"36","author":"Zlebnik","year":"2016","journal-title":"J. Neurosci."},{"key":"B160","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1590\/s0100-879x2006000400001","article-title":"Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug","volume":"39","author":"Zuardi","year":"2006","journal-title":"Braz. J. Med. Biol. Res."},{"key":"B161","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1177\/0269881108096519","article-title":"Cannabidiol for the treatment of psychosis in Parkinsons disease","volume":"23","author":"Zuardi","year":"2009","journal-title":"J. Psychopharmacol."}],"container-title":["Frontiers in Behavioral Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnbeh.2023.1137957\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T06:39:09Z","timestamp":1678948749000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnbeh.2023.1137957\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,16]]},"references-count":162,"alternative-id":["10.3389\/fnbeh.2023.1137957"],"URL":"https:\/\/doi.org\/10.3389\/fnbeh.2023.1137957","relation":{},"ISSN":["1662-5153"],"issn-type":[{"value":"1662-5153","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,16]]},"article-number":"1137957"}}